XML 18 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statement of Changes in Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
(Accumulated deficit) retained earnings
Accumulated other comprehensive loss
Treasury Stock
Common shares outstanding (in shares) at Dec. 31, 2014   195,743,154       0
Stockholders' Equity (Deficit) at Dec. 31, 2014 $ (87,297) $ 1,957 $ 57,683 $ (146,937) $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss (31)       (31)  
Exercise of stock options (in shares)   396,010        
Exercise of stock options 2,251 $ 5 2,246      
Income tax benefit from exercise of stock options 1,536   1,536      
Issuance of restricted stock (in shares)   46,750        
Issuance of restricted stock 935   935      
Issuance of common stock (in shares)   30,682        
Issuance of common stock 614   614      
Stock-based compensation expense 1,885   1,885      
Net income 89,388     89,388    
Common shares outstanding (in shares) at Dec. 31, 2015   196,216,596       0
Stockholders' Equity (Deficit) at Dec. 31, 2015 9,281 $ 1,962 64,899 (57,549) (31) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss 292       292  
Exercise of stock options (in shares)   275,543        
Exercise of stock options 1,915 $ 3 1,912      
Issuance of restricted stock (in shares)   31,871        
Issuance of restricted stock 814   814      
Stock-based compensation expense 3,795   3,795      
Net income $ 130,241     130,241    
Common shares outstanding (in shares) at Dec. 31, 2016 196,524,010 196,524,010       0
Stockholders' Equity (Deficit) at Dec. 31, 2016 $ 146,338 $ 1,965 71,420 72,692 261 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss $ (435)       (435)  
Exercise of stock options (in shares) 1,055,624 1,055,624        
Exercise of stock options $ 6,021 $ 11 6,010      
Issuance of restricted stock (in shares)   35,430        
Issuance of restricted stock 815   815      
Repurchases of common stock (in shares)           2,092,774
Repurchases of common stock (50,000)         $ (50,000)
Stock-based compensation expense 2,868   2,868      
Net income $ 193,529     193,529    
Common shares outstanding (in shares) at Dec. 31, 2017 195,522,290 197,615,064.000       2,092,774
Stockholders' Equity (Deficit) at Dec. 31, 2017 $ 299,136 $ 1,976 $ 81,113 $ 266,221 $ (174) $ (50,000)